Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770
Clinical trial NCT01060566 · COMPLETED
Trial details
- NCT number
- NCT01060566
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2010-03-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.